Abstract:Abstract Purpose To observe the immunological responses of recipients to infused lymphocytes from donors of different genetic backgrounds. Methods Mouse models were set up by mating female BALB/c mice with male C57BL mice. Splenic lymphocytes from donors of different genetic backgrounds were labeled with CFSE, and 1∙107 of the cells were intravenously injected into a recipient. At 6, 24, 72 and 120 h after the infusion, mononuclear cells in recipient spleen, liver, thymus, lymph node and peripheral blood were collected, and CFSE+, CFSE-, CD3+, CD8+, CD4+, CD19+, NK1.1+, CD25+, CD127+ lymphocytes in these samples were analyzed by flow cytometry. The distribution of donor T cells, B cells, NK cells, helper T cells, cytotoxic T cells, and recipient regulatory T cells in these tissues were then obtained. Results Maternal lymphocytes were more likely to survive in offspring. At 120 h after the infusion, the ratio of maternal cells was 0.52¡À0.11% in lymph node, 0.97¡À0.04% in peripheral blood, and 0.97¡À0.11% in spleen of the offspring. In aunt to child, father to child, and unrelated allogeneic groups at 120 h after the infusion, few donor cells, if any, were detected in these tissues. The subtype proportion of donor lymphocytes changed significantly in recipient tissues. Recipient Treg cells increased in mother to child group but not in aunt to child, father to child, and unrelated allogeneic groups, suggesting the decrease of cellular immune responses to allogeneic cells in mother to child group. At 120 h after the infusion, no donor cells were detected in recipient liver and thymus in all groups, implying that donor cells colonized hardly in liver and thymus. Conclusion Specific immune tolerance to maternal lymphocytes existed in offspring. Donor lymphocyte infusion of maternal origin may obtain a relatively persistent effect of adoptive immunotherapy with less side-effect. Figure 1. CFSE labeled donor splenic lymphocytes were infused to recipients of different kinships Figure 1. CFSE labeled donor splenic lymphocytes were infused to recipients of different kinships Black is male C57BL£¨H-2b£©mouse; white are female BALB/c mice (H-2d); the gray is offspring produced by mating C57Bland BALB/c. The lymphocyte infusion relationship between donor and recipient: ¢Ùmother to child group; ¢Úfather to child group; ¢Ûaunt to child group; ¢Üunrelated allogeneic group; ¢Ýsyngeneic group. Figure 2. The donor cells distribution according to different tissues in a case of mother¡¯ to child group infusion after 120 hours. Figure 2. The donor cells distribution according to different tissues in a case of mother¡¯ to child group infusion after 120 hours. M1 are CFSE-positive cells; M2 are the total cells. A. spleen£¨0.97¡À0.11%£©; B. liver£¨0.20¡À0.06%£©; C. thymus£¨0.01¡À0.01%£©; D. lymph nodes£¨0.52¡À0.11%£©; E. peripheral blood£¨0.97¡À0.04%£© Figure 3. Distribution of Treg cells at 120 h after infusion Figure 3. Distribution of Treg cells at 120 h after infusion Proportion of Treg cells in lymph node, peripheral blood and spleen. Treg cells increased significantly in lymph node, peripheral blood and spleen in mother to child group, as compared with those in aunt to child group, unrelated allogeneic group and control group. Disclosures No relevant conflicts of interest to declare.

Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation

Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation

Maternal Administration of Busulfan before in Utero Hematopoietic Cell Transplantation Improves Congenic Bone Marrow Cell Engraftment in a Murine Model

Beneficial Effects of Fetal-Maternal Microchimerism on the Activated Haplo-Identical Peripheral Blood Stem Cell Treatment for Cancer.

Hematopoietic Stem Cell Engraftment by Early-Stage in Utero Transplantation in a Mouse Model.

Immune modulation permits tolerance and engraftment in a murine model of late-gestation transplantation

The effect of pregnancy on paternal skin allograft survival

Effects of chimerism on the mice heart transplanted survival with the bone marrow infusion.

A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model

Survival Time of Cardiac Allografts Prolonged by Isogeneic BMT in Mice.

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation

Double Chimerism in Recipient by Transplantation of Two Allogeneic MHC-Mismatched Mouse Fetal Blood Units

Chimerism is Required for Neonatal Transplantation Tolerance

A Chimeric Mouse Model Established by Allogenic in Utero Transplantation.

Forever Connected: The Lifelong Biological Consequences of Fetomaternal and Maternofetal Microchimerism

Effects Of Noninherited Maternal Antigen On The Occurrence Of Acute Graft-Versus Host Diseae After Unmanipulated Haploidentical Blood And Marrow Transplantation

Reconstitution of the uterine immune milieu after transplantation

Adoptive Transfer of Paternal Antigen-Hyporesponsive T Cells Induces Maternal Tolerance to the Allogeneic Fetus in Abortion-Prone Matings

Early allogeneic immune modulation after establishment of donor hematopoietic cell-induced mixed chimerism in a nonhuman primate kidney transplant model

A Specific Immune Tolerance Toward Maternal Cells is Found in the Donor Lymphocyte Infusion